Immatics N.V.
IMTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001809196
In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Immatics N.V. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- +3 vs. Q2 2024
- Shares held
- 75.9M
- +143.7K (+0.2%) vs. Q2 2024
- Total value
- $865.8M
- −$14.1M (−1.6%) vs. Q2 2024
- New holders
- 16
- 18 more added
- Sold out
- 13
- 41 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $1.01B |
| Q1 2026 | 84 | $1.06B |
| Q4 2025 | 75 | $1.07B |
| Q3 2025 | 63 | $787.2M |
| Q2 2025 | 70 | $500.9M |
| Q1 2025 | 76 | $412.1M |
| Q4 2024 | 85 | $656.0M |
| Q3 2024 | 91 | $865.8M |
| Q2 2024 | 90 | $890.3M |
| Q1 2024 | 77 | $748.9M |
| Q4 2023 | 76 | $522.3M |
| Q3 2023 | 74 | $501.0M |
| Q2 2023 | 68 | $472.7M |
| Q1 2023 | 65 | $238.5M |
| Q4 2022 | 63 | $296.5M |
| Q3 2022 | 54 | $221.4M |
| Q2 2022 | 49 | $186.9M |
| Q1 2022 | 47 | $173.0M |
| Q4 2021 | 49 | $309.5M |
| Q3 2021 | 51 | $292.1M |
| Q2 2021 | 50 | $243.4M |
| Q1 2021 | 44 | $237.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Immatics N.V.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 10,000,000 | $114.1M | 1.65% | 00.0% | Unchanged |
| Wellington Management Group LLP | 9,681,183 | $110.5M | 0.02% | +144,549+1.5% | Added |
| Perceptive Advisors LLC | 8,086,159 | $92.3M | 1.98% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 7,379,636 | $84.2M | 0.05% | −54,071−0.7% | Reduced |
| Baker Bros. Advisors LP | 6,443,398 | $73.5M | 0.76% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 3,904,862 | $44.6M | 1.56% | +482,897+14.1% | Added |
| Vestal Point Capital, LP | 3,750,000 | $42.8M | 3.38% | +1,000,000+36.4% | Added |
| Price T Rowe Associates Inc | 3,494,502 | $39.9M | 0.00% | −145,060−4.0% | Reduced |
| Woodline Partners LP | 2,501,962 | $28.5M | 0.24% | −760,048−23.3% | Reduced |
| OrbiMed Advisors LLC | 2,006,381 | $22.9M | 0.42% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,920,843 | $21.9M | 0.02% | +1,035,436+116.9% | Added |
| Ra Capital Management, L.P. | 1,750,000 | $20.0M | 0.23% | 00.0% | Unchanged |
| Braidwell LP | 1,647,565 | $18.8M | 0.53% | +1,647,565 | New |
| Frazier Life Sciences Management, L.P. | 1,354,711 | $15.5M | 0.62% | +202,255+17.5% | Added |
| Wasatch Advisors Inc | 872,511 | $9.96M | 0.05% | +29,239+3.5% | Added |
| Adage Capital Partners GP, L.L.C. | 721,252 | $8.23M | 0.01% | −30,000−4.0% | Reduced |
| Sphera Funds Management Ltd. | 721,111 | $8.23M | 1.35% | −10,000−1.4% | Reduced |
| BlackRock, Inc. | 703,655 | $8.03M | 0.00% | +703,655 | New |
| 683 Capital Management, LLC | 700,000 | $7.99M | 0.81% | −115,000−14.1% | Reduced |
| University of Texas/Texas Am Investment Managment Co | 697,431 | $7.96M | 1.29% | 00.0% | Unchanged |
| Artisan Partners Limited Partnership | 661,317 | $7.55M | 0.01% | −27,167−3.9% | Reduced |
| Nantahala Capital Management, LLC | 625,659 | $7.14M | 0.60% | −162,315−20.6% | Reduced |
| ExodusPoint Capital Management, LP | 451,476 | $5.15M | 0.05% | +451,476 | New |
| StemPoint Capital LP | 449,735 | $5.13M | 1.54% | −52,472−10.4% | Reduced |
| Sofinnova Investments, Inc. | 386,100 | $4.41M | 0.36% | −410,604−51.5% | Reduced |
| TD Asset Management Inc | 359,244 | $4.21M | 0.00% | +1,718+0.5% | Added |
| Aquilo Capital Management, LLC | 333,502 | $3.81M | 4.28% | +133,502+66.8% | Added |
| JPMorgan Chase & Co | 299,066 | $3.41M | 0.00% | −22,694−7.1% | Reduced |
| Schroder Investment Management Group | 280,447 | $3.29M | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 282,193 | $3.22M | 0.03% | −137,200−32.7% | Reduced |
| Zimmer Partners, LP | 280,000 | $3.19M | 0.06% | −80,000−22.2% | Reduced |
| Affinity Asset Advisors, LLC | 250,000 | $2.85M | 0.44% | −50,000−16.7% | Reduced |
| Standard Life Aberdeen plc | 232,900 | $2.66M | 0.00% | +232,900 | New |
| State Street Corp | 225,202 | $2.57M | 0.00% | +22,710+11.2% | Added |
| Colony Group, LLC | 215,449 | $2.46M | 0.01% | +215,449 | New |
| Platinum Investment Management Ltd | 203,614 | $2.32M | 0.11% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 198,000 | $2.26M | 0.43% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 164,766 | $1.88M | 0.00% | +13,997+9.3% | Added |
| Morgan Stanley | 163,571 | $1.87M | 0.00% | −160,870−49.6% | Reduced |
| DAFNA Capital Management LLC | 145,000 | $1.65M | 0.39% | 00.0% | Unchanged |
| Crestline Management, LP | 136,721 | $1.56M | 0.09% | +10,396+8.2% | Added |
| Goldman Sachs Group Inc | 114,265 | $1.30M | 0.00% | −1,638,090−93.5% | Reduced |
| Geode Capital Management, LLC | 110,007 | $1.26M | 0.00% | −210−0.2% | Reduced |
| Two Sigma Investments, LP | 106,669 | $1.22M | 0.00% | −24,330−18.6% | Reduced |
| D. E. Shaw & Co., Inc. | 63,647 | $726.2K | 0.00% | +63,647 | New |
| Two Sigma Advisers, LP | 59,800 | $682.3K | 0.00% | −40,500−40.4% | Reduced |
| BIT Capital GmbH | 51,102 | $583.1K | 0.06% | +51,102 | New |
| Ikarian Capital, LLC | 49,415 | $563.8K | 0.18% | 00.0% | Unchanged |
| HighVista Strategies LLC | 45,544 | $519.7K | 0.18% | −32,277−41.5% | Reduced |
| Tudor Investment Corp Et Al | 36,011 | $410.9K | 0.00% | −15,368−29.9% | Reduced |
| Northern Trust Corp | 35,922 | $409.9K | 0.00% | −694−1.9% | Reduced |
| Cubist Systematic Strategies, LLC | 35,394 | $403.8K | 0.01% | −171,526−82.9% | Reduced |
| Jump Financial, LLC | 33,600 | $383.4K | 0.01% | −15,391−31.4% | Reduced |
| Mercer Global Advisors Inc | 29,877 | $334.9K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 27,587 | $314.8K | 0.00% | −3,569−11.5% | Reduced |
| Point72 Asset Management, L.P. | 26,100 | $297.8K | 0.00% | +26,100 | New |
| Corton Capital Inc. | 25,439 | $290.3K | 0.14% | +4,100+19.2% | Added |
| AlphaCentric Advisors LLC | 25,000 | $285.3K | 0.21% | +5,000+25.0% | Added |
| Pale Fire Capital SE | 24,462 | $279.1K | 0.04% | +12,938+112.3% | Added |
| Squarepoint Ops LLC | 24,282 | $277.1K | 0.00% | +24,282 | New |
| Trexquant Investment LP | 23,721 | $270.7K | 0.00% | −31,287−56.9% | Reduced |
| J. Goldman & Co LP | 22,788 | $260.0K | 0.01% | −6,750−22.9% | Reduced |
| Algert Global LLC | 21,458 | $244.8K | 0.01% | +640+3.1% | Added |
| Jane Street Group, LLC | 20,746 | $236.7K | 0.00% | −34,785−62.6% | Reduced |
| Caption Management, LLC | 18,900 | $215.6K | 0.02% | +18,900 | New |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 18,224 | $207.9K | 0.00% | −1,720−8.6% | Reduced |
| Campbell & CO Investment Adviser LLC | 14,798 | $168.8K | 0.01% | +14,798 | New |
| XTX Topco Ltd | 14,116 | $161.1K | 0.01% | −13,471−48.8% | Reduced |
| Susquehanna International Group, LLP | 13,829 | $157.8K | 0.00% | +13,829 | New |
| Voloridge Investment Management, LLC | 13,516 | $154.2K | 0.00% | −59,786−81.6% | Reduced |
| Exchange Traded Concepts, LLC | 13,155 | $150.1K | 0.00% | −4,956−27.4% | Reduced |
| Engineers Gate Manager LP | 12,729 | $145.2K | 0.00% | −12,613−49.8% | Reduced |
| Forefront Analytics, LLC | 11,180 | $127.6K | 0.06% | −807−6.7% | Reduced |
| Quarry LP | 11,000 | $125.5K | 0.04% | +2,500+29.4% | Added |
| Texas Capital Bank Wealth Management Services Inc | 10,000 | $114.1K | 0.01% | +10,000 | New |
| Virtus ETF Advisers LLC | 7,115 | $81.2K | 0.04% | +125+1.8% | Added |
| UBS Group AG | 4,751 | $54.2K | 0.00% | +989+26.3% | Added |
| Tower Research Capital LLC (TRC) | 3,606 | $41.1K | 0.00% | +3,606 | New |
| Barclays PLC | 1,434 | $16.4K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,365 | $15.6K | 0.00% | −172−11.2% | Reduced |
| Bank of America Corp | 1,344 | $15.3K | 0.00% | −43,380−97.0% | Reduced |
| Advisor Group Holdings, Inc. | 284 | $3.24K | 0.00% | −279−49.6% | Reduced |
| US Bancorp | 204 | $2.33K | 0.00% | −233−53.3% | Reduced |
| nVerses Capital, LLC | 200 | $2.28K | 0.00% | −800−80.0% | Reduced |
| GWM Advisors LLC | 104 | $1.19K | 0.00% | 00.0% | Unchanged |
| Clear Street Markets LLC | 125 | $1.00K | 0.00% | +125 | New |
| Clearstead Advisors, LLC | 80 | $913 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 14 | $160 | 0.00% | 00.0% | Unchanged |
| American Capital Advisory, LLC | 6 | $69 | 0.00% | +6 | New |
| Huntington National Bank | 1 | $11 | 0.00% | −700−99.9% | Reduced |
| Lazard Asset Management LLC | 87 | $0 | 0.00% | −1,457−94.4% | Reduced |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −946,563−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −417,810−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −393,100−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −133,284−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −58,365−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −55,283−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −22,275−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −20,552−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |